Randomized, placebo-controlled, double-blind, phase II study of axitinib plus docetaxel versus docetaxel plus placebo in patients with metastatic breast cancer

  1. Rugo, H.S.
  2. Stopeck, A.T.
  3. Joy, A.A.
  4. Chan, S.
  5. Verma, S.
  6. Lluch, A.
  7. Liau, K.F.
  8. Kim, S.
  9. Bycott, P.
  10. Rosbrook, B.
  11. Bair, A.H.
  12. Soulieres, D.
Revue:
Journal of Clinical Oncology

ISSN: 0732-183X,  1527-7755

Année de publication: 2011

Volumen: 29

Número: 18

Pages: 2459-2465

Type: Article

DOI: 10.1200/JCO.2010.31.2975 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus